Nuzefatide Pevedotin
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Nuzefatide Pevedotin, covering 2026-04-22 to 2026-04-22. Get the full timeline:
Most recent: Clinical Trial Update: A Study of Nuzefatide Pevedotin (BT5528) in Patients With Metastatic Pancreatic Ductal Adenocarcinoma (PDAC) [Phase 2]